Appropriate treatment for stage 1 and 2 HER 2 positive and triple-negative breast cancer by immigration status in Ontario, Canada.

L Lawrence Frank Paszat (Institute of Health Policy, Management and Evaluation, Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada) O Omolara Aminat Fatiregun (Lagos State University College of Medicine/Teaching Hospital, Lagos, Lagos, Nigeria) R Rinku Sutradhar (5ICES, Toronto, Canada) S Sho Podolsky (3Institute for Clinical Evaluative Sciences, Toronto, Canada) A Andrea Eisen (Department of Medical Oncology, Sunnybrook Odette Cancer Center, University of Toronto, Toronto, ON, Canada) E Eileen Rakovitch (Sunnybrook Health Sciencies, Toronto, ON, Canada)

Abstract

e12511 Background: This study explored the appropriateness of treatment received for stages 1 and 2 HER2-positive and triple-negative (TNBC) breast cancer (BC) patients with subtypes between immigrants and long-term residents. Methods: We identified women aged 18 – 75 years in the Immigration, Refugee, and Citizenship Canada Permanent Resident (CIC) database diagnosed with BC in Ontario from 2012-2019 and matched each to two long-term residents and linked to population-wide treatment databases. We categorized them into four mutually exclusive groups based on subtype (Her-2 positive vs triple negative) and breast surgery (breast-conserving surgery (BCS) vs mastectomy). Appropriate treatment included chemotherapy for all, (plus Herceptin if Her-2 overexpressing), plus breast radiation therapy if breast-conserving surgery was performed. We could not assess the receipt of endocrine therapy for the hormone receptor-positive subset of Her-2 overexpressors or indications for post-mastectomy radiation therapy. Odds ratios for receiving appropriate treatment were calculated using logistic regression adjusting for age, resource utilization and residential ethnicity concentration. Results: The analysis included 8490 women, 1538 immigrants, and 6952 long-term resident women who had a follow-up over one year. The mean age of immigrants (50.10(SD9.8)) was lower than long-term residents (54.70(SD11.13)) (p < 0.0001). Conclusions: Immigration status did not affect the receipt of appropriate treatment amongst early-stage breast cancer patients with Her2 positive or triple-negative breast cancer patients treated with either breast-conserving surgery or mastectomy in Ontario. Receipt of treatment for stages 1&2, HER2 + and triple-negative, breast cancer on adjusted analysis. Her2+ patients Breast-Conserving Surgery Mastectomy Adjusted odds Ratio 95%CL(p-value) Adjusted odds Ratio 95%CL(p-value) Immigrants vs long-term residents 0.82ref 0.65-1.04(0.09)ref 0.95ref 0.67-1.35(0.79)ref Triple Negative patients Breast-conserving Surgery Mastectomy Adjusted Odds Ratio 95%CL(p-value) Adjusted Odds Ratio 95%CL(p-value) Immigrants vs long-term residents 0.81ref 0.58-1.13(0.22)ref 0.85ref 0.49-1.46(0.55)ref

Article Details

Volume / Issue Vol. 43, Issue 16_suppl
Published June 01, 2025
ISSN 0732-183X
Publisher Lippincott Williams & Wilkins

Journal Info

Journal of Clinical Oncology

Lippincott Williams & Wilkins

ISSN: 0732-183X Health Sciences

Authors (6)

L

Lawrence Frank Paszat

Institute of Health Policy, Management and Evaluation, Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada

O

Omolara Aminat Fatiregun

Lagos State University College of Medicine/Teaching Hospital, Lagos, Lagos, Nigeria

R

Rinku Sutradhar

5ICES, Toronto, Canada

S

Sho Podolsky

3Institute for Clinical Evaluative Sciences, Toronto, Canada

A

Andrea Eisen

Department of Medical Oncology, Sunnybrook Odette Cancer Center, University of Toronto, Toronto, ON, Canada

E

Eileen Rakovitch

Sunnybrook Health Sciencies, Toronto, ON, Canada